YnnoMed is a drug R&D platform dedicated to addressing the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. Our goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections, and suppress the generation of new antimicrobial resistance. We also are able to provide drug design and discovery services by using our AI-assisted drug discovery technologies.
Global Innovation Award
"New Antibiotic Drug Candidates" invented by Dr Cong MA, Assistant Professor, Department of Applied Biology and Chemical Technology, PolyU, and Dr Xiao YANG, Research Assistant Professor, Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong
Read More . . .
Winner, Science Start-ups / Falling Walls Venture
The ONLY company from Hong Kong named as one of 25 Winners in the category of Science Start-ups (Falling Walls Venture) out of 113 Finalists. Invited to attend the Falling Walls Science Summit 2023 and Falling Walls Venture Pitch Day held in Berlin in November 2023.
48th International Exhibition of Inventions Geneva
Exhibitor representing CUHK, Hong Kong delegation
Classe M - Médecine - Chirurgie - Hygiène - Orthopédie - Matériel pour handicapés:"Série de petites molécules chimiques dont l'efficacité a été prouvée pour éliminer les bactéries pathogènes. Ces molécules antimicrobiennes ont un nouveau mécanisme d'action et un fort potentiel en tant que nouveaux candidats antibiotiques."
Read More . . . (1) (2)
"The first Elevator Pitch Competition was also held this year. 13 TSSSU-funded companies competed for four awards, delivering two-minute pitches that introduced their latest research projects. Ynno Med Limited, founded by Professor Yang Xiao, Assistant Professor, Department of Microbiology, Faculty of Medicine won the championship (please see Appendix for the winner list)."
Asia Summit on Global Health 2023 +
14th HKTDC Hong Kong International Medical and Healthcare Fair
CU Medicine x HKSTP
Prof. Yang is a microbiologist with rich experience in the research of bacterial transcription. She identified an RNA polymerase subunit in Bacillus subtilis and the encoding gene was named after her as rpoY.
Prof. Ma is dedicated to medicinal chemistry and drug discovery. He leads a team to design and discover a series of first-in-class antimicrobial agents targeting protein-protein interactions in bacterial transcription.
© Copyright 2023 by Ynno Med Limited | Department of Microbiology, Faculty of Medicine, The Chinese Unviersity of Hong Kong | Department of Applied Biology and Chemical Technology, Faculty of Science, The Hong Kong Polytechnic University